BIOMAT Database Logo BIOMAT Database Logo

Effect of zotepine, olanzapine and risperidone on hostility in schizophrenic patients. 2002

Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz

UI MeSH Term Description Entries
D010890 Pirenzepine An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients. Gastrotsepin,Gastrozepin,L-S 519,LS-519,Piren-Basan,Pirenzepin,Pirenzepin Von Ct,Pirenzepin-Ratiopharm,Pirenzepine Dihydrochloride,Pyrenzepine,Ulcoprotect,Ulgescum,Dihydrochloride, Pirenzepine,LS 519,LS519,Piren Basan,Pirenzepin Ratiopharm,Von Ct, Pirenzepin
D003988 Dibenzothiepins
D006791 Hostility Tendency to feel anger toward and to seek to inflict harm upon a person or group. Hostilities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077152 Olanzapine A benzodiazepine derivative that binds SEROTONIN RECEPTORS; MUSCARINIC RECEPTORS; HISTAMINE H1 RECEPTORS; ADRENERGIC ALPHA-1 RECEPTORS; and DOPAMINE RECEPTORS. It is an antipsychotic agent used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER; and MAJOR DEPRESSIVE DISORDER; it may also reduce nausea and vomiting in patients undergoing chemotherapy. 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine,LY 170053,LY-170052,Olanzapine Pamoate,Zolafren,Zyprexa,LY 170052,LY170052
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D001569 Benzodiazepines A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring. Benzodiazepine,Benzodiazepine Compounds
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012565 Schizophrenic Psychology Study of mental processes and behavior of schizophrenics. Psychology, Schizophrenic
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz
The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating.
April 2005, Pharmacology, biochemistry, and behavior,
Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz
The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients.
October 2006, Journal of clinical psychopharmacology,
Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
November 2001, Psychiatric services (Washington, D.C.),
Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients.
October 2012, Psychiatry research,
Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz
Direct metabolic effects of risperidone and olanzapine in Japanese schizophrenic patients.
February 2007, Neuropsychiatric disease and treatment,
Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz
Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
March 2004, Psychiatric services (Washington, D.C.),
Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz
Effect of risperidone on hostility in schizophrenia.
August 1995, Journal of clinical psychopharmacology,
Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz
Olanzapine versus risperidone in the treatment of post-psychotic depression in schizophrenic patients.
October 2005, Schizophrenia research,
Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz
Effects of risperidone and olanzapine on remnant-like lipoprotein particle cholesterol (RLP-C) in schizophrenic patients.
April 2008, Neuropsychiatric disease and treatment,
Peer Briken, and Evangelia Nika, and Steffen Moritz, and Christian Haasen, and Christian Perro, and Oktay Yagdiran, and Dieter Naber, and Michael Krausz
Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients.
June 2005, The international journal of neuropsychopharmacology,
Copied contents to your clipboard!